NCT07485933

Brief Summary

This randomized controlled study compares two methods of intraoperative cerebral ischemia monitoring during carotid endarterectomy performed under regional anesthesia: neurological testing in the awake patient and near-infrared spectroscopy (NIRS). The study aims to determine whether NIRS is equivalent to awake neurological testing in detecting cerebral ischemia during carotid artery clamping and in guiding the use of an intraluminal shunt.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
160

participants targeted

Target at P75+ for not_applicable

Timeline
17mo left

Started Dec 2025

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress32%
Dec 2025Dec 2027

Study Start

First participant enrolled

December 22, 2025

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

March 6, 2026

Completed
14 days until next milestone

First Posted

Study publicly available on registry

March 20, 2026

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2027

Last Updated

March 20, 2026

Status Verified

March 1, 2026

Enrollment Period

1.9 years

First QC Date

March 6, 2026

Last Update Submit

March 17, 2026

Conditions

Keywords

Stenosing occlusive carotid diseasecarotid endarterectomyprotective shuntneuromonitoringnear infrared spectroscopy

Outcome Measures

Primary Outcomes (1)

  • primary outcome

    to compare the incidence of intraoperative cerebral ischemia during carotid artery clamping in carotid endarterectomy when tested in the awake state, i.e. by spectroscopy (NIRS method)

    two years

Secondary Outcomes (1)

  • Secondary outcome

    2 years

Other Outcomes (1)

  • Secondary Outcome Measure 2

    2 years

Study Arms (2)

Awake Neurological Testing (TUBS) Group

ACTIVE COMPARATOR

Patients in this group will undergo carotid endarterectomy under regional anesthesia. Intraluminal shunt placement will be guided by awake neurological testing, including verbal communication and contralateral hand motor function, to detect intraoperative cerebral ischemia. NIRS monitoring will be recorded but will not guide shunt use.

Behavioral: Awake Neurological Testing

Near-Infrared Spectroscopy (NIRS) Group

ACTIVE COMPARATOR

Patients in this group will undergo carotid endarterectomy under regional anesthesia. Intraluminal shunt placement will be guided by near-infrared spectroscopy (NIRS), with shunt use indicated by a decrease of more than 20% in cerebral oxygenation compared to baseline. Awake neurological testing will be performed and recorded but will not guide shunt placement.

Device: Near-Infrared Spectroscopy (NIRS) Monitoring

Interventions

Continuous monitoring of regional cerebral oxygen saturation during carotid endarterectomy under regional anesthesia. Intraluminal shunt placement is guided by a decrease of more than 20% from baseline NIRS values. Awake neurological testing is recorded but not used for shunt decisions.

Near-Infrared Spectroscopy (NIRS) Group

Neurological monitoring during carotid endarterectomy under regional anesthesia. Intraluminal shunt placement is guided by verbal communication and contralateral hand motor testing to detect cerebral ischemia. NIRS monitoring is recorded but not used to guide shunt placement.

Awake Neurological Testing (TUBS) Group

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with asymptomatic and symptomatic narrowing of the carotid artery in whom operative treatment is indicated, diagnosed by initial Duplex ultrasonographic examination or CT angiography.
  • Written consent of the patient to participate in the study

You may not qualify if:

  • \- previous hemorrhagic stroke
  • non-atherosclerotic carotid disease
  • significant atherosclerotic changes in the aortic arch
  • hypercoagulable and conditions with embologenic potential (congenital or acquired thrombophilia, malignant disease, atrial fibrillation, significant heart failure and valvular disease)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clinic for Vascular and Endovascular Surgery, University Clinical Center of Serbia

Belgrade, 11000, Serbia

Location

MeSH Terms

Conditions

Carotid Artery Diseases

Interventions

Spectroscopy, Near-Infrared

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Diagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisSpectrum AnalysisChemistry Techniques, AnalyticalInvestigative Techniques

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This randomized controlled trial compares awake neurological testing and near-infrared spectroscopy (NIRS) for detecting intraoperative cerebral ischemia during carotid endarterectomy under regional anesthesia. The study evaluates whether NIRS is equivalent to awake testing in identifying cerebral hypoperfusion and guiding intraluminal shunt placement.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 6, 2026

First Posted

March 20, 2026

Study Start

December 22, 2025

Primary Completion (Estimated)

December 1, 2027

Study Completion (Estimated)

December 1, 2027

Last Updated

March 20, 2026

Record last verified: 2026-03

Locations